Kaur H, Karabulut S, Gauld J, Fagot S, Holloway K, Shaw H
Psychedelic Med (New Rochelle). 2025; 1(3):166-185.
PMID: 40046567
PMC: 11661495.
DOI: 10.1089/psymed.2023.0023.
Alsaad A
Cureus. 2024; 16(9):e70060.
PMID: 39449896
PMC: 11499728.
DOI: 10.7759/cureus.70060.
Aziz-Zadeh L, Mayer E, Labus J, Ringold S, Jayashankar A, Kilroy E
Res Sq. 2024; .
PMID: 39108481
PMC: 11302680.
DOI: 10.21203/rs.3.rs-4559624/v1.
Blum K, Bowirrat A, Sunder K, Thanos P, Hanna C, Gold M
Brain Sci. 2024; 14(7).
PMID: 39061473
PMC: 11274922.
DOI: 10.3390/brainsci14070733.
Esposito D, Cruciani G, Zaccaro L, di Carlo E, Spitoni G, Manti F
Brain Sci. 2024; 14(5).
PMID: 38790459
PMC: 11119126.
DOI: 10.3390/brainsci14050481.
Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.
Wegiel J, Chadman K, London E, Wisniewski T, Wegiel J
Autism Res. 2024; 17(7):1300-1321.
PMID: 38500252
PMC: 11272444.
DOI: 10.1002/aur.3123.
Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD production, and AhR activation in autism spectrum disorder.
Launay J, Delorme R, Pagan C, Callebert J, Leboyer M, Vodovar N
Transl Psychiatry. 2023; 13(1):380.
PMID: 38071324
PMC: 10710433.
DOI: 10.1038/s41398-023-02687-w.
The enteric nervous system deficits in autism spectrum disorder.
Wang X, Tang R, Wei Z, Zhan Y, Lu J, Li Z
Front Neurosci. 2023; 17:1101071.
PMID: 37694110
PMC: 10484716.
DOI: 10.3389/fnins.2023.1101071.
Impact of the circadian nuclear receptor REV-ERBα in dorsal raphe 5-HT neurons on social interaction behavior, especially social preference.
Jang S, Park I, Choi M, Kim J, Yeo S, Huh S
Exp Mol Med. 2023; 55(8):1806-1819.
PMID: 37537215
PMC: 10474013.
DOI: 10.1038/s12276-023-01052-7.
Maternal LPS Exposure Enhances the 5-HT Level in the Prefrontal Cortex of Autism-like Young Offspring.
Lin F, Wang X, Luo R, Yuan B, Ye S, Yang T
Brain Sci. 2023; 13(6).
PMID: 37371436
PMC: 10295954.
DOI: 10.3390/brainsci13060958.
Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics.
Maurer J, Choi A, An I, Sathi N, Chung S
Neurobiol Sleep Circadian Rhythms. 2023; 14:100095.
PMID: 37188242
PMC: 10176270.
DOI: 10.1016/j.nbscr.2023.100095.
Candidate biomarkers in psychiatric disorders: state of the field.
Abi-Dargham A, Moeller S, Ali F, DeLorenzo C, Domschke K, Horga G
World Psychiatry. 2023; 22(2):236-262.
PMID: 37159365
PMC: 10168176.
DOI: 10.1002/wps.21078.
Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and -KO mouse models.
Sharghi S, Flunkert S, Daurer M, Rabl R, Chagnaud B, Leopoldo M
Front Neurosci. 2023; 17:1087788.
PMID: 37065917
PMC: 10097904.
DOI: 10.3389/fnins.2023.1087788.
Autism-like behaviors regulated by the serotonin receptor 5-HT2B in the dorsal fan-shaped body neurons of Drosophila melanogaster.
Cao H, Tang J, Liu Q, Huang J, Xu R
Eur J Med Res. 2022; 27(1):203.
PMID: 36253869
PMC: 9575255.
DOI: 10.1186/s40001-022-00838-1.
Intestinal Predictors of Whole Blood Serotonin Levels in Children With or Without Autism.
Zuniga-Kennedy M, Davoren M, Shuffrey L, Luna R, Savidge T, Prasad V
J Autism Dev Disord. 2022; 52(9):3780-3789.
PMID: 35726077
DOI: 10.1007/s10803-022-05597-w.
Targeting 5-HT as a Potential Treatment for Social Deficits in Autism.
Yang G, Geng H, Hu C
Neurosci Bull. 2022; 38(10):1263-1266.
PMID: 35536504
PMC: 9554180.
DOI: 10.1007/s12264-022-00876-z.
Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review.
Tan Z, Wei H, Song X, Mai W, Yan J, Ye W
Front Neurosci. 2022; 16:806876.
PMID: 35495051
PMC: 9043810.
DOI: 10.3389/fnins.2022.806876.
Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder.
Kuo H, Liu F
Biomedicines. 2022; 10(3).
PMID: 35327362
PMC: 8945169.
DOI: 10.3390/biomedicines10030560.
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.
Markopoulos A, Inserra A, De Gregorio D, Gobbi G
Front Pharmacol. 2022; 12:749068.
PMID: 35177979
PMC: 8846292.
DOI: 10.3389/fphar.2021.749068.
The meaning of significant mean group differences for biomarker discovery.
Loth E, Ahmad J, Chatham C, Lopez B, Carter B, Crawley D
PLoS Comput Biol. 2021; 17(11):e1009477.
PMID: 34793435
PMC: 8601419.
DOI: 10.1371/journal.pcbi.1009477.
